Inhalation Spray-Based Drugs Market

Inhalation based dosage forms are intended for direct delivery of medicament to lungs to produce local or systematic effects. Inhalation spray-based systems consist of drug formulation (solution, suspension or dry powder) and container-closure system, which do not contain any propellant.

Inhalation Spray-Based Drugs Market contains market size and forecasts of Inhalation Spray-Based Drugs in global, including the following market information:

Global Inhalation Spray-Based Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Inhalation Spray-Based Drugs Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Inhalation Spray-Based Drugs companies in 2021 (%)

The global Inhalation Spray-Based Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Inhalation Spray-Based Drugs include Roxane Laboratories (subsidiary of West-Ward Pharmaceuticals), Allergan, CHIESI Farmaceutici, Serenity Pharmaceuticals, Boehringer Ingelheim, GlaxoSmithKline, Teva Pharmaceuticals, AstraZeneca and Opko Health. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Inhalation Spray-Based Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Inhalation Spray-Based Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Inhalation Spray-Based Drugs Market Segment Percentages, by Type, 2021 (%)

Corticosteroids

Bronchodilators

Antihistamines

Combination Drugs

Global Inhalation Spray-Based Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Inhalation Spray-Based Drugs Market Segment Percentages, by Application, 2021 (%)

Hospital Pharmacy

Retail Pharmacy

Drug Stores

Clinics

Global Inhalation Spray-Based Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Inhalation Spray-Based Drugs Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Inhalation Spray-Based Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Inhalation Spray-Based Drugs revenues share in global market, 2021 (%)

Key companies Inhalation Spray-Based Drugs sales in global market, 2017-2022 (Estimated), (MT)

Key companies Inhalation Spray-Based Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roxane Laboratories (subsidiary of West-Ward Pharmaceuticals)

Allergan

CHIESI Farmaceutici

Serenity Pharmaceuticals

Boehringer Ingelheim

GlaxoSmithKline

Teva Pharmaceuticals

AstraZeneca

Opko Health